Clinical Trial Update: Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Aeroquin to Tobramycin Inhalation Solution in cystic fibrosis patients has completed, with results posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Aeroquin (levofloxacin for inhalation)
• Tobramycin Inhalation Solution (tobramycin inhalation solution)

Snippet

Sponsor: Amgen | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-21